Ogilvie syndrome risk factors

Jump to navigation Jump to search
Ogilvie syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ogilvie syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ogilvie syndrome risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ogilvie syndrome risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ogilvie syndrome risk factors

CDC on Ogilvie syndrome risk factors

Ogilvie syndrome risk factors in the news

Blogs on Ogilvie syndrome risk factors

Directions to Hospitals Treating Ogilvie syndrome

Risk calculators and risk factors for Ogilvie syndrome risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]

Overview

Common risk factors of Ogilvie's syndrome include having neurologic disorders, taking narcotic medications, and trauma. Other risk factors include systemic lupus erythematosusalcoholism, and multiple myeloma.

Risk Factors

Common risk factors for Ogilvie's syndrome include the following:[1][2]

Less common risk factors for Ogilvie's syndrome include the following:[3]

References

  1. Ogilvie Syndrome as a Postoperative Complication Patty L. Tenofsky, MD; R. Larry Beamer, MD; R. Stephen Smith, MD Arch Surg. 2000;135:682-687.
  2. Sreter KB, Barisic B, Popovic-Grle S (2017). "Pharmacogenomics and tailored polypharmacy: an 80-year-old lady with rosuvastatin-associated rhabdomyolysis and maprotiline-related Ogilvie's syndrome". Int J Clin Pharmacol Ther. 55 (5): 442–448. doi:10.5414/CP202784. PMID 28257284.
  3. García López CA, Laredo-Sánchez F, Malagón-Rangel J, Flores-Padilla MG, Nellen-Hummel H (2014). "Intestinal pseudo-obstruction in patients with systemic lupus erythematosus: a real diagnostic challenge". World J Gastroenterol. 20 (32): 11443–50. doi:10.3748/wjg.v20.i32.11443. PMC 4145788. PMID 25170234.